Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes Vaccine Trial Offers New Hope Posted: Thursday, December 14, 2006

Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.

Diabetes Drug Shows Promises as Fatty Liver Treatment Posted: Thursday, December 07, 2006

Actos is a drug used by millions of diabetics to control their blood may be valuable in preventing a common overlooked liver problem as well.

Nasal Insulin Expands Trial for Postpranidal Hyperglycemia Indication Posted: Thursday, December 07, 2006

Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley's human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Medication Nonadherence Prevalent in Diabetics is Associated with Adverse Outcom Posted: Thursday, December 07, 2006

Medication nonadherence was significantly associated with increased risks for all-cause hospitalization and for all-cause mortality.

ACE Inhibitors Reduce Kidney Disease Risk in Diabetics with High Blood Pressure Posted: Thursday, December 07, 2006

In diabetic patients with hypertension, ACE inhibitors reduce the risk of developing diabetes-related kidney disease, independent of their effect in lowering blood pressure, reports a study in the December Journal of the American Society of Nephrology.

Statins in Our Drinking Water? Posted: Thursday, December 07, 2006

If Fluoride in our drinking water prevents cavities then why not statins? Statins found to reduce heart attacks by 29% and strokes by 14% in those without heart disease.

Januvia Combo Soon to Be Available - JANUMET Posted: Thursday, December 07, 2006

Within weeks of Januvia being approved, Merck & Co. is ready to come out with a combination product of Januvia and metformin.

Pfizer Drops Trials on Heart Drug Posted: Thursday, December 07, 2006

End of research on cholesterol medicine torcetrapib is a big blow for firm.

Naturlose A New Treatment for Diabetes Begins Phase 3 Trials Posted: Thursday, December 07, 2006

Naturlose has a beneficial effect on modulating postprandial blood glucose.

Results Announced from ADOPT (A Diabetes Outcome Progression Trial) Posted: Thursday, December 07, 2006

Landmark Study compares effectiveness of single therapy with rosiglitazone, sulfonylurea and metformin in a head to head comparison with 4360 newly diagnosed Type 2’s.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.